Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus

European Journal of Clinical Investigation

Volumn 36, Issue 11, 2006, Pages 796-802

  Guerrero Romero, F ^a,b   Rodriguez Moran M ^b  

^a Research Group on Diabetes and Chronic Illnesses ^*  (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Beta cell function; Impaired glucose tolerance; Insulin secretion; Insulin sensitivity; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; DISEASE COURSE; EVALUATION; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; PREDIABETIC STATE;

EID: 33750003355     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2006.01728.x     Document Type: Article

References (32)

1. Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of β-cell function. The hyperbolic correction. Diabetes 2002;51 (Suppl. 1):S212-20.
2. Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis if type II diabetes mellitus. Diabetologia 2001;44:929-45.
3. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981;68:1456-67.
4. Polonsky KS, Sturis J, Bell GI. Non-insulin-dependent diabetes mellitus - A genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 1996;334:777-83.
5. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
6. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van Haeften T et al. Use of the oral glcuose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295-301.
7. Hermans MP, Levy JC, Morris RJ, Turner RC. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 1999;42:678-87.
8. Legro RS, Finegood D, Dunaifa A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycistic ovary syndrome. J Clin Endocrinol Metab 1988;83:2694-8.
9. Raynaud E, Perez-Martín A, Brun J-F, Benhaddad AA, Mercier J. Revised concept for the estimation of insulin sensitivity from a single sample. Diabetes Care 1999;22:1003-4 (letter).
10. Belfiore F, Lannello S, Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 1998;63:134-41.
11. Duncan MH, Singh BM, Wise PH, Carter G, Alaghband-Zadeh J. A simple measure of insulin resistance. Lancet 1995;346:120-1.
12. Celderholm J, Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 1990;10:167-75.
13. Katz A, Nambi SS, Mather K, Baron AD, Follman DA, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10.
14. Guerrero-Romero F, Rodríguez-Morán M, González-Ortiz M, Martínez-Abundis E. Insulin action and secretion in healthy Hispanic-Mexican first-degree relatives of subjects with type 2 diabetes. J Endocrinol Invest 2001;24:580-6.
15. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW et al. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes 1993;42:1663-72.
16. Weyer Ch, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999;104:787-94.
17. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003;46:3-19.
18. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin dependent diabetes mellitus. Prospectives studies of Pima Indians. N Engl J Med 1993;329:1988-92.
19. Cavaghan MK. Ehrmann DA, Polonsky K. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 2000;106:329-33.
20. Hanley AJG, Williams K, Gonzalez C, D'Agostino Jr RB, Wagenknecht LE, Stern MP, et al. Prediction of Type 2 diabetes using simple measures of insulin resistance. Combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 2003;52:463-9.
21. Tapia Conyer R. Encuesta Nacional de Enfermedades Crónicas. Secretaría de Salud, Dirección general de Epidemiología. México, D.F.; 1993: 18-24.
22. Yaney GC, Corkey BE. Fatty acid metabolism and insulin secretion in pancreatic beta cells. Diabetologia 2003;46:1297-312.
23. Boden G, Laakso M. Lipids and glucose in type 2 diabetes. What is the cause and effect? Diabetes Care 2004;27:2253-9.
24. Guerrero-Romero F, Alvarado-Ruiz R, Rodriguez-Moran M. Accumulated probability of hypertension in diabetes and of diabetes in hypertension. Rev Invest Clin 1998;50:281-5.
25. Gerstein HC, Anand S, Yi QL, Vuksan V, Lonn E, Teo K et al. For the SHARE Investigators. The Relationship between dysglycemia and atherosclerosis in south Asian, Chinese, and European individuals in Canada. A randomly sampled cross-sectional study. Diabetes Care 2003;26:144-9.
26. Grundy SM. Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds. J Am Coll Cardiol 2006;47:1093-100.
27. Sowers JR, Epsteinm M, Frohlich ED. Diabetes, hypertension and cardiovascular disease. An update. Hypertension 2001;37:1053-9.
28. Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk Communities Study. N Engl J Med 2000;342:905-12.
29. Ferrannini E, Mari A. Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 2004;47:943-56.
30. Albareda M, Rodríguez-Espinoza J, Murugo M, De Leiva A, Corcoy R. Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 2000;43:1507-11.
31. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modelling. Diabetes Care 2004;27:1487-95.
32. Hermans MP, Levy JC, Morris RJ, Turner RC. Comparison of tests of β-cell function across a range glucose tolerance from normal to diabetes. Diabetes 1999;48:1779-86.